A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52)

Author： von Minckwitz Gunter   Conrad Bettina   Reimer Toralf   Decker Thomas   Eidtmann Holger   Eiermann Wolfgang   Hackmann John   Möbus Volker   Marmé Frederik   Potenberg Jochem   Stickeler Elmar   Simon Eike   Thomssen Christoph   Huober Jens   Denkert Carsten   Alfer Joachim   Jackisch Christian   Nekljudova Valentina   Burchardi Nicole   Loibl Sibylle   von Minckwitz Gunter  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|20|3639-3648

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.20, 2015-10, pp. : 3639-3648

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer

By Ho Cheryl   Davies Angela   Sangha Randeep   Lau Derick   Lara Primo   Chew Helen   Beckett Laurel   Mack Philip   Riess Jonathan   Gandara David  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1587-1591

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer

By Kumar Aalok   Kennecke Hagen F.   Renouf Daniel J.   Lim Howard J.   Gill Sharlene   Woods Ryan   Speers Caroline   Cheung Winson Y.  

Cancer, Vol. 121, Iss. 4, 2015-02 ,pp. : 527-534

Blackwell Publishing

Access to resources Recommend Favorite

Capecitabine versus Bolus Fluorouracil plus Leucovorin (Folinic Acid) as Adjuvant Chemotherapy for Patients with Dukes' C Colon Cancer: Economic Evaluation in an Italian NHS Setting

By Francesco Di Costanzo  

Clinical Drug Investigation, Vol. 28, Iss. 10, 2008-01 ,pp. : 645-655

Adis International

Access to resources Recommend Favorite

Capecitabine plus paclitaxel in metastatic breast cancer

By  

Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Capecitabine combined with docetaxel versus vinorelbine followed by capecitabine maintenance medication for first-line treatment of patients with advanced breast cancer: Phase 3 randomized trial

By  

Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. : 3412-3421

Blackwell Publishing

Access to resources Recommend Favorite